{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"97.000","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"66,677,133","primaryexch":"HKEX","ric":"2630.HK","product_subtype":null,"db_updatetime":"06 Nov 2025 09:36","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BVK9VY4","am":"383.44","iv":"","ew_strike":"","as":"91.000","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"90.750","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-11-06 01:36:31.0","lo52":"","shares_issued_date":"6 Nov 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Tian Guanghui","underlying_ric":"2630.HK","hi52":"","issuer_name":"Vigonvita Life Sciences Co., Ltd. - B - H Shares","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"06 Nov 2025 10:20","aum_date":"","lo":"88.000","mkt_cap":"6.05","f_aum_hkd":null,"ew_sub_per_to":"","ls":"90.800","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"0","aum":"","issued_shares_class_B":null,"vo":"4.34","secondary_listing_flag":false,"listing_date":"6 Nov 2025","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Vigonvita Life Sciences Co., Ltd. - B - H Shares","nm_s":"VIGONVITA-B","sym":"2630","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.050","strike_price":"","summary":"Vigonvita Life Sciences Co Ltd is a China-based company mainly engaged in the discovery, development and commercialization of small molecule drugs. The Company mainly focuses on the fields of neuropsychiatric, reproductive health and viral infection treatment. The Company's product pipeline mainly includes LV232, TPN102, VV119, VV147, TPN171, VV913, VV116, VV261 and VV207. The Company has entered the commercialization stage. The Company mainly operates its businesses in the domestic market.","op":"95.000","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"8th Floor, Building A<br/>No. 108, Yuxin Road<br/>Suzhou Industrial Park Dist<br/>Suzhou, PRC","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"CNE1000076N3","moneyness":""}},"qid":"1762396554775"}
